Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thomas P. Soloway CFO of TSPT bought for 2.68 and sold for 7.8$ right after approval
How come CFO OF tspt sold his shares right after approval, did'nt he has any confidence in share price.
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0001181431-11-057709%2Etxt&FilePath=%5C2011%5C11%5C28%5C&CoName=TRANSCEPT+PHARMACEUTICALS+INC&FormType=4&RcvdDate=11%2F28%2F2011&pdf=
How high can this go?
Jazz also went from $8 to 49$ & now it is at $36 change.....
There are 24 form (4)'s submitted on SEC, all insiders sold transactions pretty much everything in the range between 41$ and 43$
Insiders sold lot of shares, if pps reaching $50 or higher why would they sell their shares?
Now a days these analysts giving price targets which are ridiculous...
Have you seend TSPT options nothing beyong 12.50$
It fell like a rock within 60 seconds from 9.05 to 7.5$
Transcept Pharmaceuticals upgraded to Buy from Hold at MLV Equity
MLV Equity upgraded Transcept Pharmaceuticals citing expectations for an FDA approval of the company's insomnia treatment Intermezzo.
http://finance.yahoo.com/news/Transcept-Pharmaceuticals-theflyonthewall-3054209051.html?x=0&.v=1
Transcept Pharmaceuticals upgraded to Buy from Hold at MLV Equity
MLV Equity upgraded Transcept Pharmaceuticals citing expectations for an FDA approval of the company's insomnia treatment Intermezzo.
http://finance.yahoo.com/news/Transcept-Pharmaceuticals-theflyonthewall-3054209051.html?x=0&.v=1
Who are you, how can they tell you the results.
I looked up on net about FDA spokeswoman Shelly Burgess.
Looks ridiculous.
Momentum, Are you in SMSI
Looks good, Lion Master also bought expecting a bounce:
http://www.thelion.com/bin/forum.cgi?tf=wall_street_pit&msg=2149638&cmd=r&t=0&dt=1
Momentum, Do you have the link of FDA catalyst dates for all Phase 1, phase 2, & phase 3 data info plus FDA PDUFA dates web site.
I remember few months ago you have posted a link here on IHUB.
Thanks.
PTIE FDA REJECTED DRUG 50% DOWN
MOMENTUM ARE U IN?
What happens when 17000 Options contract puts expire tomorrow, is it similar to short covering?
-----------
China MedicalExpress (CCME) is reeling today after the NASDAQ de-listed the stock. Shares had been halted since March amid allegations the company misrepresented financials. CCME is down $6.94 to $2.19 and options volume is 1,650 calls and 17,000 puts. The action is liquidating trades. The Options Clearing Corporation is only allowing closing trades and no new positions can be initiated in CCME.
-----------
Tomorrow options expiration day, 17000 put option contracts.
Guaranteed short covering tomorrow.
GLTA.
i bought thru tdameritrade, traded 3 times.
Now final block waiting to sell.
Where did you get this Number? short shares: 6,234,131
SPPI FDA approval is NOT Fusilev for colon cancer. It's simply a "ready to use" formulation.
Teva in talks with AVANIR.....RUMOR on Yahoo message board.
AH HGSI going high on CNBC by Mark Schoenebaum
Mark Schoenebaum is a respected Biotech analyst. He tells it like it is and has no agenda.
I was disappointed that he was seeing a 30% raise over the next 6 months. That is only a $7 increase over the current price.
When they asked him about buyouts I think he may have believed it would happen but it sounded more like he was hedging.
He did say that in all the years he has been an analyst that he has never seen a panel recommend a stock with a such a high vote (13-2) and see the stock go down. It surprised him. If you read between the lines I think he believes HGSI will go up and soon.
AH HGSI going high - ON CNBC: Mark Schoenebaum is a respected Biotech analyst. He tells it like it is and has no agenda.
I was disappointed that he was seeing a 30% raise over the next 6 months. That is only a $7 increase over the current price.
When they asked him about buyouts I think he may have believed it would happen but it sounded more like he was hedging.
He did say that in all the years he has been an analyst that he has never seen a panel recommend a stock with a such a high vote (13-2) and see the stock go down. It surprised him. If you read between the lines I think he believes HGSI will go up and soon.
Savient seeing potential interest from suitors, Dealreporter says citing sources
November 17, 2010
11:39 EDT SVNT theflyonthewall.com: Savient seeing potential interest from suitors, Dealreporter says citing sources
http://www.theflyonthewall.com/permalinks/entry.php/SVNTid1308392/SVNT-Savient-may-be-exploring-a-sale-Dealreporter-reports
Savient seeing potential interest from suitors, Dealreporter says citing sources
November 17, 2010
11:39 EDT SVNT theflyonthewall.com: Savient seeing potential interest from suitors, Dealreporter says citing sources
http://www.theflyonthewall.com/permalinks/entry.php/SVNTid1308392/SVNT-Savient-may-be-exploring-a-sale-Dealreporter-reports
Savient seeing potential interest from suitors, Dealreporter says citing sources
November 17, 2010
11:39 EDT SVNT theflyonthewall.com: Savient seeing potential interest from suitors, Dealreporter says citing sources
http://www.theflyonthewall.com/permalinks/entry.php/SVNTid1308392/SVNT-Savient-may-be-exploring-a-sale-Dealreporter-reports
Savient seeing potential interest from suitors, Dealreporter says citing sources
November 17, 2010
11:39 EDT SVNT theflyonthewall.com: Savient seeing potential interest from suitors, Dealreporter says citing sources
http://www.theflyonthewall.com/permalinks/entry.php/SVNTid1308392/SVNT-Savient-may-be-exploring-a-sale-Dealreporter-reports
Savient seeing potential interest from suitors, Dealreporter says citing sources
November 17, 2010
11:39 EDT SVNT theflyonthewall.com: Savient seeing potential interest from suitors, Dealreporter says citing sources
http://www.theflyonthewall.com/permalinks/entry.php/SVNTid1308392/SVNT-Savient-may-be-exploring-a-sale-Dealreporter-reports
APPA above $0.80, for last 12 trading session on green.
News may be coming with respect to the NDA resubmission.
APPA above $0.80, for last 12 trading session on green.
News may be coming with respect to the NDA resubmission.
APPA above $0.80, for last 12 trading session on green.
News may be coming with respect to the NDA resubmission.
APPA above $0.80, for last 12 trading session on green.
News may be coming with respect to the NDA resubmission.
APPA above $0.80, for last 12 trading session on green.
News may be coming with respect to the NDA resubmission.
Wallstarb, Whats your opinion on ALXA? how low can the share price GO.
Thank you.
COCO new lows
COCO new lows
COCO new lows
For-Profit Colleges Seek Shares Revival, Reprieve on U.S. Rules
COCO is @ year low....
http://www.bloomberg.com/news/2010-11-04/for-profit-colleges-seek-shares-revival-reprieve-on-u-s-rules.html?cmpid=yhoo
For-profit colleges, whose stocks have lost 32 percent this year, are likely to get help from Republicans to ease limits on federal grants and loans that provide the bulk of education companies’ revenue.
Republican Representative John Kline from Minnesota, in line to become chairman of the House Committee on Education and Labor, has criticized a proposed U.S. Education Department regulation that ties for-profit colleges’ eligibility for student aid to whether graduates pay back their loans. The department today begins two days of hearings on the so-called gainful employment rule.
For-profit colleges may also ask lawmakers to extend a provision easing a rule that can cut their access to student aid when more than 90 percent their revenue comes from government sources. Apollo Group Inc., the biggest U.S. education company, and Corinthian Colleges Inc. have said some of their campuses are likely to violate the rule in the coming year.
“There’s optimism that Republicans will change the higher education debate in Washington and prevent some of the most onerous regulations and legislation from taking effect,” said Jarrel Price, an analyst with Height Analytics in Washington, in a telephone interview yesterday.
Phoenix-based Apollo fell 32 cents, or less than 1 percent, to $38.47 yesterday in Nasdaq Stock Market composite trading. An index of 13 for-profit college stocks fell 2.5 percent.
Republican Takeover
Republicans won a majority in the House of Representatives in the Nov. 2 election, gaining at least 60 seats, their biggest increase since 1938.
Education Secretary Arne Duncan delayed issuing the gainful employment rule after receiving 90,000 comment letters. Kline feels the measure, scheduled to take effect in 2012, unnecessarily hurts for-profit colleges and their students, said Alexa Marrero, a spokeswoman for the congressman. Kline called the proposed rule “confusing and complex,” in an Aug. 2 letter to the agency.
“Our preferred approach is to ensure greater disclosure and transparency on the part of institutions,” Marrero said in a telephone interview. “Information about graduation and job placement is better than the federal government coming in and deciding which schools are best for students.”
Republicans may seek to soften the rule either by negotiating with the administration on its other goals, such as expanded early childhood education, or by advancing legislation to revoke some of or the entire proposal, Price said. Either approach will present a challenge, he said.
‘Horse-Trading’
“It’s unclear whether Republicans can bring gainful employment to the horse-trading block,” he said. “It’s an uphill battle for them to get legislative proposals past a Democratic Senate filibuster or a presidential veto.”
While Republicans are more sensitive to for-profit colleges’ concerns about regulation, the industry must still show that its programs are worthy of government support, said Harris Miller, president and chief executive officer of the Association of Private Sector Colleges and Universities in Washington. Some Republicans have called for widespread budget cuts that might affect the Pell Grant program, he said. For- profit colleges received about $7.3 billion in student Pell Grant aid in the 2009-2010 academic year, according to the Education Department.
“We have to show that taxpayers and students are getting a good return on their investments, particularly if budget control and spending control become a central theme,” he said.
90/10 Rule
Education companies are particularly concerned about the expiration of the law that has eased the “90/10 rule” for two years, Miller said. Companies got the relief because of the abrupt increase in aid that became available to students as the Obama administration expanded the Pell Grant program, pushing many for-profit colleges close to the 90 percent limit, he said.
“We’re asking for another year of extension to create time for the marketplace to adjust and stay compliant,” he said. Companies that violate the 90/10 rule two years in a row can lose access to government aid.
Senator Tom Harkin, the Iowa Democrat who heads the Senate education committee, has commissioned a government probe of for- profit colleges and held three hearings on their sales tactics, use of government funds and program quality. Harkin has scheduled a fourth hearing in December that will likely scrutinize enrollments of military personnel, said Jeff Silber, an analyst with BMO Capital Markets in New York, in a note to clients yesterday. Federal spending on veterans’ education will more than double this year to $9.6 billion from $4.2 billion in 2009, according to the U.S. Department of Veterans Affairs.
Legislative Changes
Harkin said Sept. 30 he’s planning “legislative changes” for the education industry. Republicans will now likely block those efforts, said Robert Froehlich, chief investment strategist at Hartford Financial Services Group Inc. Hartford’s mutual funds unit manages about $95 billion.
Democrats “wanted to figure out some way of congressional control and oversight of that industry,” he said yesterday in a telephone interview. “There is no way that happens with Republicans controlling the House, so that industry has really got to be popping the champagne bottles.”
While Democrats retained control of the Senate, Republicans on the Senate education committee have criticized Harkin’s scrutiny. Senator Mike Enzi of Wyoming, the highest ranking Republican on the committee, walked out of a September hearing saying Harkin was determined to “beat up” on for-profit colleges. Republican Senator John McCain of Arizona, who was re- elected Nov. 2, also walked out of the hearing.
To contact the reporter on this story: John Lauerman in Boston at jlauerman@bloomberg.net
For-Profit Colleges Seek Shares Revival, Reprieve on U.S. Rules
COCO is @ year low....
http://www.bloomberg.com/news/2010-11-04/for-profit-colleges-seek-shares-revival-reprieve-on-u-s-rules.html?cmpid=yhoo
For-profit colleges, whose stocks have lost 32 percent this year, are likely to get help from Republicans to ease limits on federal grants and loans that provide the bulk of education companies’ revenue.
Republican Representative John Kline from Minnesota, in line to become chairman of the House Committee on Education and Labor, has criticized a proposed U.S. Education Department regulation that ties for-profit colleges’ eligibility for student aid to whether graduates pay back their loans. The department today begins two days of hearings on the so-called gainful employment rule.
For-profit colleges may also ask lawmakers to extend a provision easing a rule that can cut their access to student aid when more than 90 percent their revenue comes from government sources. Apollo Group Inc., the biggest U.S. education company, and Corinthian Colleges Inc. have said some of their campuses are likely to violate the rule in the coming year.
“There’s optimism that Republicans will change the higher education debate in Washington and prevent some of the most onerous regulations and legislation from taking effect,” said Jarrel Price, an analyst with Height Analytics in Washington, in a telephone interview yesterday.
Phoenix-based Apollo fell 32 cents, or less than 1 percent, to $38.47 yesterday in Nasdaq Stock Market composite trading. An index of 13 for-profit college stocks fell 2.5 percent.
Republican Takeover
Republicans won a majority in the House of Representatives in the Nov. 2 election, gaining at least 60 seats, their biggest increase since 1938.
Education Secretary Arne Duncan delayed issuing the gainful employment rule after receiving 90,000 comment letters. Kline feels the measure, scheduled to take effect in 2012, unnecessarily hurts for-profit colleges and their students, said Alexa Marrero, a spokeswoman for the congressman. Kline called the proposed rule “confusing and complex,” in an Aug. 2 letter to the agency.
“Our preferred approach is to ensure greater disclosure and transparency on the part of institutions,” Marrero said in a telephone interview. “Information about graduation and job placement is better than the federal government coming in and deciding which schools are best for students.”
Republicans may seek to soften the rule either by negotiating with the administration on its other goals, such as expanded early childhood education, or by advancing legislation to revoke some of or the entire proposal, Price said. Either approach will present a challenge, he said.
‘Horse-Trading’
“It’s unclear whether Republicans can bring gainful employment to the horse-trading block,” he said. “It’s an uphill battle for them to get legislative proposals past a Democratic Senate filibuster or a presidential veto.”
While Republicans are more sensitive to for-profit colleges’ concerns about regulation, the industry must still show that its programs are worthy of government support, said Harris Miller, president and chief executive officer of the Association of Private Sector Colleges and Universities in Washington. Some Republicans have called for widespread budget cuts that might affect the Pell Grant program, he said. For- profit colleges received about $7.3 billion in student Pell Grant aid in the 2009-2010 academic year, according to the Education Department.
“We have to show that taxpayers and students are getting a good return on their investments, particularly if budget control and spending control become a central theme,” he said.
90/10 Rule
Education companies are particularly concerned about the expiration of the law that has eased the “90/10 rule” for two years, Miller said. Companies got the relief because of the abrupt increase in aid that became available to students as the Obama administration expanded the Pell Grant program, pushing many for-profit colleges close to the 90 percent limit, he said.
“We’re asking for another year of extension to create time for the marketplace to adjust and stay compliant,” he said. Companies that violate the 90/10 rule two years in a row can lose access to government aid.
Senator Tom Harkin, the Iowa Democrat who heads the Senate education committee, has commissioned a government probe of for- profit colleges and held three hearings on their sales tactics, use of government funds and program quality. Harkin has scheduled a fourth hearing in December that will likely scrutinize enrollments of military personnel, said Jeff Silber, an analyst with BMO Capital Markets in New York, in a note to clients yesterday. Federal spending on veterans’ education will more than double this year to $9.6 billion from $4.2 billion in 2009, according to the U.S. Department of Veterans Affairs.
Legislative Changes
Harkin said Sept. 30 he’s planning “legislative changes” for the education industry. Republicans will now likely block those efforts, said Robert Froehlich, chief investment strategist at Hartford Financial Services Group Inc. Hartford’s mutual funds unit manages about $95 billion.
Democrats “wanted to figure out some way of congressional control and oversight of that industry,” he said yesterday in a telephone interview. “There is no way that happens with Republicans controlling the House, so that industry has really got to be popping the champagne bottles.”
While Democrats retained control of the Senate, Republicans on the Senate education committee have criticized Harkin’s scrutiny. Senator Mike Enzi of Wyoming, the highest ranking Republican on the committee, walked out of a September hearing saying Harkin was determined to “beat up” on for-profit colleges. Republican Senator John McCain of Arizona, who was re- elected Nov. 2, also walked out of the hearing.
To contact the reporter on this story: John Lauerman in Boston at jlauerman@bloomberg.net
AVNR Nice Article today from Tom Bustamante.
Tom Bustamante, Managing Partner of Ludlow Capital,thinks Avanir is a good buyout target and says pps can top 10.00 soon.. Hold Folks.. HOLD..
GLTA.
AVNR Nice Article today from Tom Bustamante.
Tom Bustamante, Managing Partner of Ludlow Capital,thinks Avanir is a good buyout target and says pps can top 10.00 soon.. Hold Folks.. HOLD..
GLTA.
AVNR: WedBush Raising 2011 Sales Expectations and Price Target to $13 from $9.
http://pics.newsware.com/fc.asp?key=fc_sxb09420&date=2010-11-02
AVNR: WedBush Raising 2011 Sales Expectations and Price Target to $13 from $9.
http://pics.newsware.com/fc.asp?key=fc_sxb09420&date=2010-11-02
Are You Motivated By Pain? SVNT NEWS
If you’ve never experienced the painful symptoms of gout, consider yourself lucky. The buildup of uric acid crystals in joints has been likened to having skewers pushed into flesh.
It’s estimated that over one million people suffer from gout attacks every year - and if a person with a proverbial skewer sticking out of their joints isn’t a motivated buyer, I don’t know who would be.
The company I’m talking about today markets a specialized gout treatment. There are other gout treatments on the market, but this company’s treatment targets chronic cases that haven't responded to other medications. The company has put the potential number of patients at around 172,000, and industry watchdogs have estimated potential annual worldwide sales could range from a low $200 million to upwards of $1 billion. The company has indicated in regulatory filings that the drug would be relatively cheap to manufacture.
http://finance.yahoo.com/news/Are-You-Motivated-By-smallcapinvestor-3226704029.html?x=0&.v=1
APPA volume spiked 14 times higer than daily AVg.
Stock moving.
APPA volume spiked 14 times higher than daily AVG, stock above 4 month high.